Novartis Ag NVS
NYSE NVS
$140.35 -0.58 (-0.41%)
At close: Sep 18, 2026 · 4:00 PM EDT

Novartis Ag (NVS) Amortization - Intangibles (2009 - 2014)

Novartis Ag's (NVS) quarterly Amortization - Intangibles came in at -$2.9 billion in Q4 2014, up 4.17% year-over-year from -$2.7 billion in Q4 2013, and up 4.17% quarter-over-quarter from -$3.0 billion in Q4 2013.

Analysis

Novartis Ag (NVS) Amortization - Intangibles (2009 - 2014) Analysis & Trends

Novartis Ag has disclosed Amortization - Intangibles across 6 years of filings, most recently posting -$2.9 billion for Q4 2014.

  • In Q4 2014, Amortization - Intangibles rose 4.17% year-over-year to -$2.9 billion; the TTM figure through Dec 2014 stood at -$11.8 billion (down 34.27% YoY), while the FY2023 annual figure was -$171.0 million, up 95.71% from the prior year.
  • Amortization - Intangibles came in at -$2.9 billion for Q4 2014 at Novartis Ag, up from -$3.0 billion in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $164.0 million in Q1 2010 to a low of -$3.0 billion in Q4 2011.
  • Average Amortization - Intangibles over 5 years is -$1.8 billion, with a median of -$2.9 billion recorded in 2014.
  • Year-over-year, Amortization - Intangibles slumped 166.78% in 2011 and gained 4.43% in 2012.
  • Over 5 years, Amortization - Intangibles stood at -$1.1 billion in 2010, then plunged by 166.78% to -$3.0 billion in 2011, then rose by 4.43% to -$2.9 billion in 2012, then decreased by 2.83% to -$3.0 billion in 2013, then gained by 4.17% to -$2.9 billion in 2014.
  • Per Business Quant data, the three most recent Amortization - Intangibles figures were -$2.9 billion in Q4 2014, -$3.0 billion in Q4 2013, and -$2.9 billion in Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -2.85 Bn
Dec 31, 2013 -2.98 Bn
Dec 31, 2012 -2.89 Bn
Dec 31, 2011 -3.03 Bn
Mar 31, 2011 147.00 Mn
Dec 31, 2010 -1.14 Bn
Mar 31, 2010 164.00 Mn
Dec 31, 2009 -1.03 Bn